|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar
|
|
2
|
Ettinger DS, Wood DE, Aggarwal C, Aisner
DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac
LR, et al: NCCN guidelines insights: Non-small cell lung cancer,
version 1.2020. J Natl Compr Canc Netw. 17:1464–1472. 2019.
View Article : Google Scholar
|
|
3
|
Chen Z, Fillmore CM, Hammerman PS, Kim CF
and Wong KK: Non-small-cell lung cancers: A heterogeneous set of
diseases. Nat Rev Cancer. 14:535–546. 2014. View Article : Google Scholar
|
|
4
|
Besse B, Adjei A, Baas P, Meldgaard P,
Nicolson M, Paz-Ares L, Reck M, Smit EF, Syrigos K, Stahel R, et
al: 2nd ESMO consensus conference on lung cancer: Non-small-cell
lung cancer first-line/second and further lines of treatment in
advanced disease. Ann Oncol. 25:1475–1484. 2014. View Article : Google Scholar
|
|
5
|
Pillai RN and Ramalingam SS: Advances in
the diagnosis and treatment of non-small cell lung cancer. Mol
Cancer Ther. 13:557–564. 2014. View Article : Google Scholar
|
|
6
|
Rolfo C, Giovannetti E, Hong DS, Bivona T,
Raez LE, Bronte G, Buffoni L, Reguart N, Santos ES, Germonpre P, et
al: Novel therapeutic strategies for patients with NSCLC that do
not respond to treatment with EGFR inhibitors. Cancer Treat Rev.
40:990–1004. 2014. View Article : Google Scholar
|
|
7
|
Hagenbuch B and Meier PJ: The superfamily
of organic anion transporting polypeptides. Biochim Biophys Acta.
1609:1–18. 2003. View Article : Google Scholar
|
|
8
|
Abe T, Unno M, Onogawa T, Tokui T, Kondo
TN, Nakagomi R, Adachi H, Fujiwara K, Okabe M, Suzuki T, et al:
LST-2, a human liver-specific organic anion transporter, determines
methotrexate sensitivity in gastrointestinal cancers.
Gastroenterology. 120:1689–1699. 2001. View Article : Google Scholar
|
|
9
|
Hagenbuch B and Meier PJ: Organic anion
transporting polypeptides of the OATP/SLC21 family: Phylogenetic
classification as OATP/SLCO superfamily, new nomenclature and
molecular/functional properties. Pflugers Arch. 447:653–665. 2004.
View Article : Google Scholar
|
|
10
|
Obaidat A, Roth M and Hagenbuch B: The
expression and function of organic anion transporting polypeptides
in normal tissues and in cancer. Annu Rev Pharmacol Toxicol.
52:135–151. 2012. View Article : Google Scholar
|
|
11
|
Yamaguchi H, Okada M, Akitaya S, Ohara H,
Mikkaichi T, Ishikawa H, Sato M, Matsuura M, Saga T, Unno M, et al:
Transport of fluorescent chenodeoxycholic acid via the human
organic anion transporters OATP1B1 and OATP1B3. J Lipid Res.
47:1196–1202. 2006. View Article : Google Scholar
|
|
12
|
Nagai M, Furihata T, Matsumoto S, Ishii S,
Motohashi S, Yoshino I, Ugajin M, Miyajima A, Matsumoto S and Chiba
K: Identification of a new organic anion transporting polypeptide
1B3 mRNA isoform primarily expressed in human cancerous tissues and
cells. Biochem Biophys Res Commun. 418:818–823. 2012. View Article : Google Scholar
|
|
13
|
Thakkar N, Kim K, Jang ER, Han S, Kim K,
Kim D, Merchant N, Lockhart AC and Lee W: A cancer-specific variant
of the SLCO1B3 gene encodes a novel human organic anion
transporting polypeptide 1B3 (OATP1B3) localized mainly in the
cytoplasm of colon and pancreatic cancer cells. Mol Pharm.
10:406–416. 2013. View Article : Google Scholar
|
|
14
|
Sun Y, Furihata T, Ishii S, Nagai M,
Harada M, Shimozato O, Kamijo T, Motohashi S, Yoshino I, Kamiichi
A, et al: Unique expression features of cancer-type organic anion
transporting polypeptide 1B3 mRNA expression in human colon and
lung cancers. Clin Transl Med. 3:372014. View Article : Google Scholar
|
|
15
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar
|
|
16
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View
Article : Google Scholar
|
|
17
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar
|
|
18
|
Prudkin L, Liu DD, Ozburn NC, Sun M,
Behrens C, Tang X, Brown KC, Bekele BN, Moran C, Moran C and
Wistuba II: Epithelial-to-mesenchymal transition in the development
and progression of adenocarcinoma and squamous cell carcinoma of
the lung. Mod Pathol. 22:668–678. 2009. View Article : Google Scholar
|
|
19
|
Liu D, Huang C, Kameyama K, Hayashi E,
Yamauchi A, Kobayashi S and Yokomise H: E-Cadherin expression
associated with differentiation and prognosis in patients with
non-small cell lung cancer. Ann Thorac Surg. 71:949–955. 2001.
View Article : Google Scholar
|
|
20
|
Thomson S, Buck E, Petti F, Griffin G,
Brown E, Ramnarine N, Iwata KK, Gibson N and Haley JD: Epithelial
to mesenchymal transition is a determinant of sensitivity of
non-small-cell lung carcinoma cell lines and xenografts to
epidermal growth factor receptor inhibition. Cancer Res.
65:9455–9462. 2005. View Article : Google Scholar
|
|
21
|
Rho JK, Choi YJ, Lee JK, Ryoo BY, Na II,
Yang SH, Kim CH and Lee JC: Epithelial to mesenchymal transition
derived from repeated exposure to gefitinib determines the
sensitivity to EGFR inhibitors in A549, a non-small cell lung
cancer cell line. Lung Cancer. 63:219–226. 2009. View Article : Google Scholar
|
|
22
|
Chun SE, Thakkar N, Oh Y, Park JE, Han S,
Ryoo G, Hahn H, Maeng SH, Lim YR, Han BW and Lee W: The N-terminal
region of organic anion transporting polypeptide 1B3 (OATP1B3)
plays an essential role in regulating its plasma membrane
trafficking. Biochem Pharmacol. 131:98–105. 2017. View Article : Google Scholar
|
